Evolus (EOLS) director granted 45,559 restricted stock units at no cost

Rhea-AI Filing Summary

Stewart Brady reported acquisition or exercise transactions in this Form 4 filing.

Evolus, Inc. director Stewart Brady reported receiving a grant of 45,559 shares of common stock in the form of restricted stock units (RSUs). The award was priced at $0.00 per share, increasing his directly held common stock (including RSUs) to 134,188 shares after the transaction.

Each RSU represents a contingent right to receive one Evolus common share. The RSUs will vest in full on the one-year anniversary of February 17, 2026, if Brady remains in continuous service through the vesting date, with potential accelerated vesting upon certain changes of control of the company.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Stewart Brady

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	45,559	$0.00	--

Holdings After Transaction: Common Stock — 134,188 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stewart Brady

(Last) (First) (Middle)

520 NEWPORT CENTER DRIVE

SUITE 1200

(Street)

NEWPORT BEACH CA 92660

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Evolus, Inc. [ EOLS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/17/2026		A		45,559(1)	A	$0	134,188	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 17, 2026, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.

Remarks:

	/s/ Jeffrey J. Plumer, as attorney-in-fact for Brady Stewart	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Evolus (EOLS) director Stewart Brady report in this Form 4?

Stewart Brady reported an acquisition of 45,559 shares of Evolus common stock through a grant of restricted stock units. These RSUs were awarded at a price of $0.00 per share and increased his total direct holdings to 134,188 shares after the transaction.

How many Evolus (EOLS) shares were granted to Stewart Brady and at what price?

Stewart Brady was granted 45,559 restricted stock units representing Evolus common stock at a price of $0.00 per share. Each RSU entitles him to receive one share of common stock upon settlement, subject to vesting conditions and continued service requirements.

What is the vesting schedule for Stewart Brady’s Evolus (EOLS) RSU grant?

The 45,559 RSUs granted to Stewart Brady will vest in full on the one-year anniversary of February 17, 2026. Vesting requires that he remain in continuous service through that date, with potential accelerated vesting upon certain specified changes of control of Evolus.

What does each restricted stock unit (RSU) represent in the Evolus (EOLS) Form 4?

Each RSU granted to Stewart Brady represents a contingent right to receive one share of Evolus common stock. The units convert into actual shares only upon vesting and settlement, which depend on his continued service and any applicable change-of-control acceleration provisions.

How many Evolus (EOLS) shares does Stewart Brady hold after this RSU grant?

Following the RSU grant, Stewart Brady’s total directly held Evolus common stock, including the newly awarded units, is 134,188 shares. This figure reflects his ownership position immediately after the reported grant and incorporates the 45,559 RSUs disclosed in the Form 4.